Standard BioTools's market cap is currently ―. The company's EPS TTM is $-0.995; its P/E ratio is -2.55; Standard BioTools is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 28.19M	$ 25.37M	$ 27.67M	$ 25.12M	$ 27.02M
Gross Profit	$ 10.78M	$ 11.15M	$ 13.60M	$ 12.12M	$ 48.96M
EBIT	$ -18.84M	$ -19.72M	$ -15.61M	$ -15.46M	$ -19.59M
EBITDA	$ -15.87M	$ -16.74M	$ -12.60M	$ -12.46M	$ -16.58M
Net Income Common Stockholders	$ -19.78M	$ -21.00M	$ -17.04M	$ -16.84M	$ -20.84M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 114.89M	$ 128.85M	$ 142.30M	$ 154.54M	$ 165.78M
Total Assets	$ 323.07M	$ 339.29M	$ 355.83M	$ 371.65M	$ 390.31M
Total Debt	$ 98.21M	$ 99.72M	$ 101.39M	$ 101.98M	$ 102.67M
Net Debt	$ -16.68M	$ -29.13M	$ -40.92M	$ -52.55M	$ -63.11M
Total Liabilities	$ 159.87M	$ 159.75M	$ 157.96M	$ 157.55M	$ 160.52M
Stockholders Equity	$ -148.05M	$ -131.72M	$ -113.39M	$ -97.15M	$ -81.47M
Cash Flow	-
Free Cash Flow	$ -14.14M	$ -12.32M	$ -10.17M	$ -9.49M	$ -19.94M
Operating Cash Flow	$ -14.06M	$ -11.41M	$ -9.33M	$ -8.48M	$ -19.18M
Investing Cash Flow	$ -13.12M	$ -49.93M	$ 40.13M	$ 43.15M	$ 40.24M
Financing Cash Flow	$ -1.00M	$ -1.16M	$ -2.08M	$ -2.59M	$ -270.00K

Currency in USD

Standard BioTools Earnings and Revenue History

Income Statement >

Standard BioTools Debt to Assets

Balance Sheet >

Standard BioTools Cash Flow

Cash Flow >

Standard BioTools Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing